Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction.
about
Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gelDevelopment of an LC-MS method for measuring TNF in human vaginal tissue.Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007Measurement of antiretroviral drugs in the lungs of HIV-infected patients.Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxisImmunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women.An accurate and precise high-performance liquid chromatography method for the rapid quantification of the novel HIV integrase inhibitor raltegravir in human blood plasma after solid phase extractionSensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicineSimultaneous determination of mycophenolic acid and its glucuronide and glycoside derivatives in canine and feline plasma by UHPLC-UV.Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women.Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gaThe pharmacokinetics and viral activity of tenofovir in the male genital tractTenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16(INK4a) expression in subjects on combination therapy.Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigationsSpectrophotometric simultaneous determination of Tenofovir disoproxil fumarate and Emtricitabine in combined tablet dosage form by ratio derivative, first order derivative and absorbance corrected methods and its application to dissolution study.Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: Application to human pharmacokinetics.HPTLC Method for the Simultaneous Estimation of Emtricitabine and Tenofovir in Tablet Dosage Form.Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.Simultaneous Spectrophotometric Method for Determination of Emtricitabine and Tenofovir Disoproxil Fumarate in Three-Component Tablet Formulation Containing Rilpivirine Hydrochloride.Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms.HPLC method for the determination of emtricitabine and related degradation substances.Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometry.Synthesis and evaluation of molecularly imprinted polymeric microspheres for highly selective extraction of an anti-AIDS drug emtricitabine.Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.Optimization (central composite design) and validation of HPLC method for investigation of emtricitabine loaded poly(lactic-co-glycolic acid) nanoparticles: in vitro drug release and in vivo pharmacokinetic studies.Stability-Indicating High-Performance Thin-Layer Chromatographic Method for Quantitative Estimation of Emtricitabine in Bulk Drug and Pharmaceutical Dosage FormStress studies of tenofovir disoproxil fumarate by HPTLC in bulk drug and pharmaceutical formulationHigh-Performance Liquid Chromatographic Method for Analysis of Emtricitabine in Rat Plasma: Method Development, Validation and Application to a Pharmacokinetic StudyA Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Tenofovir, Emtricitabine, and a Efavirenz and Statistical Approach to Determine the Effect of VariablesSimple Spectrophotometric Methods for Determination of Tenofovir Fumarate and Emtricitabine in Bulk Powder and in TabletsExtractive Spectrophotometric Determination of Tenofovir Disoproxil Fumarate Using Acidic Triphenylmethane Dyes
P2860
Q28473376-58113933-ACD9-4C8E-9FA4-2E7CBC92F3FBQ33787052-C48BF6DB-6CCB-4E64-A77B-C68778445DB8Q33814896-284742F4-6C4E-4C55-92A2-F06442C734F4Q33818018-325B98CF-5F29-44F5-B02E-D033ABD002B2Q33821257-870E9688-3896-46D0-B32C-25F85D3AD4B7Q35102123-EAED80CF-97FC-4321-9029-2590DA4125C9Q35781692-FBBFE246-BDC7-4140-95E2-ADB8FF9643A4Q35821916-6577569C-B147-4E12-B2E2-741E5443A2EBQ36266188-915CBD9D-7001-4DC2-8AE6-C03D58EA092EQ36430073-C38BED0C-2765-4D40-8636-7B88DB774006Q36876279-FFF4BD38-3C00-4F22-AEAE-4618A32902AFQ37204271-CB456112-8202-4DB3-9132-48CF2FF7B9B7Q37271173-E6229B94-14B1-4307-BCE0-382738052D5BQ37275103-618C8465-5A00-4580-A07F-4A961F082C99Q37304746-A5979108-9CA5-4A9E-9740-B64B2B975891Q37607042-620E9472-4918-4E1D-A596-A949943A1423Q37669191-AAE06281-8B01-49B6-A8CD-AF0722A82FE4Q40829396-41604144-8550-41CB-BECC-1B4ACBF1D2A3Q41218781-97F545B9-1618-4F03-8949-9BA2DC523FA4Q41819346-F8A22CF5-33F5-4949-9D4E-58260A93BF3FQ41830503-45BB2F3A-A011-4C89-ABF1-CED16BA73723Q41871402-045C39A4-701F-4AD9-8BFE-062198E8E013Q42575236-BC3B7C65-BDB4-4217-9791-F923A1E99E94Q43438728-412E4692-C353-43E6-BEA8-54CAF2C4AB7DQ45113899-341BBC78-5DA1-4D34-97F1-815BAFE2C1D8Q45929804-DE0EFD56-87FF-44B3-8915-412DBA623319Q46791174-7FCBE11F-D7E1-4312-A26B-03FDE2B76978Q55170368-F07B7618-504F-481D-9927-30F409BD3956Q58690264-DC8F99C2-D3FC-4614-B934-084DACD8FCDCQ58915110-CDB091F4-2E10-4E56-957D-4814E36EE73BQ58994217-A66D20AC-6F0D-4406-84C0-F9DD1027B53DQ59000214-CA2CF01F-7323-4DE6-872F-CAC6F8E39B8AQ59021211-1EC1C504-5A12-430C-83C9-BCA1D0B8A1DFQ59048735-1A73E14C-5570-4BE1-84A2-C1F2201D754B
P2860
Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Simultaneous quantification of ...... after solid phase extraction.
@en
Simultaneous quantification of ...... after solid phase extraction.
@nl
type
label
Simultaneous quantification of ...... after solid phase extraction.
@en
Simultaneous quantification of ...... after solid phase extraction.
@nl
prefLabel
Simultaneous quantification of ...... after solid phase extraction.
@en
Simultaneous quantification of ...... after solid phase extraction.
@nl
P2093
P1476
Simultaneous quantification of ...... after solid phase extraction.
@en
P2093
Angela D M Kashuba
Naser L Rezk
Rustin D Crutchley
P304
P356
10.1016/J.JCHROMB.2005.06.019
P577
2005-08-01T00:00:00Z